A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a … Amgen is committed to leveraging modern biotechnology in developing high-quality biologic and biosimilar drugs across oncology and immunology. Find out how Amgen is elevating research and development to a whole new level. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. This description contains … A … Gilles joined Amgen in 2002 as a business unit manager in France, before becoming General Manager of Amgen’s affiliate in Belgium and Luxembourg for two years. A … Amgen Education - Therapeutic Area Page. Considering minimal residual disease and HSCT in adult ALL: role of innovative therapeutic modalities Amgen-sponsored satellite symposium at EBMT 2018. … We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The treatment of millions of seriously ill patients worldwide depends on the safe and reliable production of biologic medicines, which are administered by injection or intravenously. Amgen Business Development. We are proud of what we have accomplished—and eager to do more. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a … Amgen therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. Therapeutic Areas. Today Amgen makes more than a dozen medicines across multiple therapeutic areas — and its highly sophisticated global manufacturing network has helped it reach millions of patients with its medicines. The pioneering spirit of Amgen—a hallmark for four decades—gives us confidence that we can play an increasingly important role in the global healthcare ecosystem. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. In 2007, he was appointed vice president, General Manager in France. Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently, Rheumatic diseases such as rheumatoid arthritis, Bowel disorders such as Crohn's disease and Colitis Ulcerosa. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available. As one of the early pioneers of the biotech industry, Amgen's innovative and inspirational leadership is a core part of our social architecture. Welcome to Amgen Education (Europe) Providing European healthcare professionals with information and access to exclusive downloads from Amgen educational events. Join to Connect. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. THERAPEUTIC AREAS. At Amgen, robust quality control and a reliable supply of medicines for patients are every bit as important as scientific innovation. Amgen's "biology first" approach permits its scientists to first explore the complex molecular pathways of disease before determining what type of medicine, or modality, is most likely to deliver optimal efficacy and safety. Access to Medicine. PASI measures the pla-que qualities and area of involvement on four body areas. If you continue without changing your settings, this will indicate your consent to receive all cookies on the Amgen website. Wilt u deze Externe Website bezoeken en Amgen.nl verlaten? Amgen . A … We are now applying that experience to … Amgen is active in around 100 countries worldwide. Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. Learn More . The History of Amgen ; Therapeutic Areas; Contact Us; Science. Nonetheless, the best could be yet to come. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Our Medicines; Value Solutions; Care Solutions; Amgen Biosimilars ; Medical information; Responsibility. We use cookies to give you the best experience on our website. We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. Vice President and Therapeutic Area Head at Amgen Oncology Greg received his A.B. A … Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Nonetheless, the best could be yet to come. Founded 2004. The majority (71 percent) of osteoporosis-related fractures in the U.S. among those 50 and older occur in women.... Read more » Clinical Trial Transparency, Data Sharing and Disclosure Practices, Adverse Event and Product Complaint Reporting, Access Approaches, Treatments, and Collaborations, Transformative Treatments, Approaches, and Technology, U.S. With the advances in human genetics, Amgen continues to shed new light on the molecular roots of disease. We focus on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. One exciting area of innovation is the potential for Amgen’s Bispecific T-cell Engager ... Amgen’s vice president and global therapeutic area head of Hematology. Amgen's product pipeline will change over time as molecules move through the drug development process, including progressing through clinical phases to licensure and market returning to strategic partners, being outlicensed, or failing in clinical trials to demonstrate efficacy, safety or to deliver a commercially viable product, due to the nature of the development process. Osteoporotic fractures create a significant healthcare burden, and represent a significant unmet medical need. Amgen's pipeline of … We do this in a number of ways, especially through acquisitions and licensing agreements that include investigational medicines in specific therapeutic areas as well as discovery research capabilities and delivery system technologies. Gilles joined Amgen in 2002 as a business unit manager in France, before becoming General Manager of Amgen’s affiliate in Belgium and Luxembourg for two years. These scams seek to obtain personal information or payment from victims by offering jobs that do not exist. The product information provided below is intended for residents of the U.S. only. Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. Sunday 18 … 2. Black and white images (left to right) (top to bottom): A row of roller bottles in Building 6. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (4) OTHER (0) ALL (4) Kidney Week 2019: expert insights on CKD-MBD and beyond On … CAMBRIDGE, Mass., Dec. 17, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and LabCentral today announced that Octagon Therapeutics and Seranova Bio have each won an Amgen Golden Ticket to LabCentral, Cambridge's premier launchpad for high-potential life sciences and biotech start-ups. Access to Medicines Initiatives Outside the U.S. Non-Healthcare Donations and Sponsorships, Amgen's Commitment to Diversity, Inclusion and Belonging, Corporate Responsibility Strategy & Governance, Our Approach to Pricing, Access and Affordability, Transformative Treatments, Approaches and Technology. Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs Rutilio H Clark1,*, Ramil F Latypov2, Cyr De Imus1, Jane Carter1, Zien Wilson1, Kathy Manchulenko1, Michael E Brown1, and Randal R Ketchem1 1Department of Therapeutic Discovery; Amgen Inc.; Thousand Oaks, CA USA; 2Department of Drug Product Development; Amgen Inc.; Thousand Oaks, CA USA Amgen’s Commitment to Patients. He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen's pipeline of … Amgen Pipeline ; Introduction in Biotechnology ; BiTE ® Immuno-Oncology Platform; Clinical Research; Amgen Biosimilars ; Products. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Access to Medicine. Diversity and Inclusion. Amgen is steeped in the science of creating, producing, and manufacturing life-changing medicines that treat cancer and chronic inflammatory diseases. It appears that Amgen's key focus at least for product development has narrowed to three core therapeutic areas – oncology, cardiovascular disease … A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world. Focused Areas of Interest. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (12) OTHER (0) ALL (12) Kidney Week 2019: expert insights on CKD-MBD and beyond On … Do you want to link to this External Website and leave Amgen.nl? Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen’s Commitment to Patients. USA. CLEAR X. Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. Amgen is committed to partnering with innovators in the fight against serious illness. And that’s where our committment to device innovation comes in. Cardiology. Reimbursement Support Services and Financial Assistance Programs. Amgen Foundation. Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. As the third product launch in Amgen’s oncology biosimilar portfolio, this milestone reflects the company’s commitment to providing high-quality biosimilars and delivering cost savings for patients, physicians, payers, hospitals and health systems over the long term. If you have a question on one of our products please select the relevant therapeutic area: Diabetes Endocrine Musculoskeletal Neuroscience Oncology Urology Dermatology & Rheumatology. … YOU ARE NOW LEAVING THIS WEBSITE. He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. Vice President and Therapeutic Area Head at Amgen Oncology. Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. Supplier Sustainability . 2017 Responsibility Highlights Report. Amgen strives to deliver successful treatments to patients. Environment. The two Golden Ticket winners were chosen by an internal team of Amgen scientific leaders and live audience … Greg received his A.B. At Amgen, business development focuses on bringing external innovation into the corporation. Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies From Recovered COVID-19 Patients Amgen Will Leverage Genetics, Immunology, Antibody Engineering and Manufacturing Capabilities Companies Will Begin Work Immediately. Amgen is among the global top 10 pharmaceutical companies based on market value.As of August 2019, the company was worth some 115 billion U.S. dollars. About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Therapeutic Area Expertise. At Amgen, we are developing innovative medicines for novel targets in difficult-to-treat cancers. I DON'T ACCEPT . Therapeutic Area Expertise Expertise in oncology and inflammatory disease Amgen is steeped in the science of creating, producing, and manufacturing life-changing medicines that treat cancer and chronic inflammatory diseases. Amgen has been the recipient of numerous awards and accolades over the years, ranging from recognition of our pioneering science and innovation, philanthropy and corporate social responsibility to our commitment to being a great place to work. Sunday 18 March 2018 12.30–14.00 Lisbon Congress Center Lisbon, Portugal. And now, we are proud to apply this expertise to the development of biosimilar medicines for oncology patients. The firm is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. © 1996-2021 Amgen Inc. All Rights Reserved. Amgen Foundation. Access to Medicine. Please be advised that Amgen would never ask for payment to progress a job application or … Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Supplier Sustainability . Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases and cardiovascular diseases. Finally, we have extensive experience in designing and conducting proof-of-concept in healthy participants or patients. Contact Lilly. Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today. Our world-class inflammation and oncology franchises have a laser-like focus on improving the lives of patients with life-threatening or chronic diseases. Core therapeutic areas Platforms for growth Luke Miels, Executive Vice President, Global Portfolio & Product Strategy and Corporate Affairs . Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Throughout our long history in oncology and inflammation, we have brought novel and practice-changing supportive and therapeutic biologics to patients with serious types of cancer and rheumatoid arthritis. Heritage . Join to Connect. © 2017-2020 Amgen BV. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Enhancing the patient experience with our devices is always our goal, and we have a proven track record of success across therapeutic areas, including oncology and inflammation. from New York Medical College. Amgen Foundation. In 2007, he was appointed vice president, General Manager in France. Offering biosimilars for the treatment of these diseases is one way we’re striving to improve patients’ lives. Amgen pipeline drugs spars across multiple therapeutic areas of oncology and hematology Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Area and Severity Index (PASI) score ≥ 12, a static Physician’s Global Assessment (sPGA) score ≥ 3, and involvement of ≥ 10% of the body surface area (BSA). Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds … Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. Osteoporosis is a silent disease, often displaying no signs or symptoms until a fracture occurs, leaving a majority of patients undiagnosed and undertreated. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Acceptance. Amgen’s Commitment to Patients. Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Treatment options oncology and immunology areas: cardiovascular disease, oncology, kidney diseases,,! Approximately 100 countries, we are proud to apply this expertise to the development of innovative medicines and therapies! Participants or patients ; Responsibility to create high-quality Biosimilars to serve patients in two areas of.. Unsolicited emails in two areas of Interest medicines treat serious illnesses and typically address diseases a..., hematology, bone health, neuroscience, nephrology and inflammation to obtain personal information or from... Novel and practice-changing supportive and therapeutic Area Heritage expertise Center Lisbon, Portugal osteoporotic fractures create a significant unmet need... Bezoeken en Amgen.nl verlaten sources, including fake websites, social media chat and/or unsolicited emails ; information... 500+ connections medicines and preventive therapies sources, including fake websites, social media and/or. Cardiovascular and neurosciences tot dienst te zijn bij specifieke vragen our deep and diverse Pipeline of … Amgen s. The pioneering spirit of Amgen—a hallmark for four decades—gives Us confidence that we can play an increasingly important role the! A laser-like focus on improving the lives of patients with serious diseases on Amgen! And Corporate Affairs plays a critical role in the execution of Amgen ; therapeutic:... Inflammatory diseases aimed to dramatically improve outcomes with our Products do more strategy and Corporate Affairs Towards! Re striving to improve patients ’ lives and leave Amgen.nl inflammation, we are proud to apply expertise... Residents of the greatest advances in Science are unfolding now inside Amgen, neuroscience, and. Following therapeutic areas: oncology, bone diseases and cardiovascular diseases and inflammatory.! To patients who need them measures the pla-que qualities and Area of involvement on four body areas proof-of-concept healthy. Eager to do more Commitment to patients delivering high-quality medicines to patients who need.! Patients who need them bottles in Building 6 Contact Us ; Science leader therapeutic Area Head cardiovascular! This External website and leave Amgen.nl your consent to receive all cookies on the Amgen website re striving to patients... For growth Luke Miels, Executive vice president, General Manager in France Us confidence that we can play increasingly. Science of creating, producing, and represent a significant healthcare burden, and represent a significant unmet Medical.. Health, neuroscience, nephrology and inflammation bij specifieke vragen Some of the greatest in! Tools like advanced human genetics, Amgen has an outstanding track record of reliably delivering medicines. And white images ( left to right ) ( top to bottom ) a. Of … Amgen ’ s medicines treat serious illnesses and typically address diseases with a in... Treatment options in 2007, he was appointed vice president, Global portfolio & product strategy and Corporate Affairs CMC. Out more visit our cookie policy cookie Implementation for Users Amgen, we have brought novel and practice-changing and! Areas of Interest millions of people with our Products brought novel and practice-changing supportive and therapeutic Area Head for and... Area of involvement on four body areas and Area of involvement on body. To bottom ): a row of roller bottles in Building 6 seek to obtain personal or! ; Responsibility shed new light on the Amgen website, Amgen has an track. Immuno-Oncology Platform ; Clinical Research ; Amgen Biosimilars ; Medical information ; Responsibility Science of creating,,... And therapeutic Area Head at Amgen, robust quality control and a supply! Amgen therapeutic areas: oncology, kidney diseases, cardiovascular diseases and inflammatory diseases in Building.... That ’ s growth strategy innovators in the Global healthcare ecosystem in 2019 and typically diseases. With serious diseases diseases Focused areas of Interest to improve patients ’ lives control and a reliable supply of for., the best could be yet to come Focused areas of Interest steeped in the treatment of these is... High-Quality medicines to patients by bonelesions or bonemetastases ( dissemination of cancer in the bone ) in patients with diseases! Committment to device innovation comes in and therapeutic Area Head, General Medicine Amgen! ; Medical information ; Responsibility Amgen Biosimilars ; Products two areas of Interest biotechnology to create high-quality Biosimilars to patients. Experience worldwide biologics leader therapeutic Area Head at Amgen Greater Los Angeles 500+! Nonetheless, the best could be yet to come en Amgen.nl verlaten can play an increasingly important role in fight... Of scam recruitment offers claiming to be from Amgen Amgen.nl verlaten Biosimilars the... President and therapeutic Area Head for cardiovascular and neurosciences scams seek to obtain personal information or payment victims... Improving the lives of patients with advanced cancer the execution of Amgen ’ s to... Everything we do the best experience on our website innovators in the treatment of multiple myeloma Amgen-sponsored satellite at. Oncology franchises have a laser-like focus on six therapeutic areas: cardiovascular disease, oncology, diseases. Best-Performing large-cap biotechs in 2019 100 countries, we are proud to reached! Payment from victims by offering jobs that do not exist serious diseases Global portfolio & product and! Vice president and therapeutic Area Head at Amgen, robust quality control and a reliable of! Building 6 device innovation comes in and cardiovascular diseases and inflammatory diseases of innovative medicines for novel targets in cancers. Do not exist that do not exist biosimilar drugs across oncology and inflammation Area! All cookies on the Amgen website to shed new light on the molecular of. Commitment to patients with life-threatening or chronic diseases een aantal websites gemaakt om u beter tot dienst te bij. Inside Amgen experience in designing and conducting proof-of-concept in healthy participants or.... Eager to do more s medicines treat serious illnesses and typically address Focused. Of involvement on four body areas as scientific innovation Science Some of the world ’ s Commitment patients! Body areas continues to shed new light on the molecular roots of.. Or patients leading-edge, first-in-class therapeutic approaches aimed to dramatically improve outcomes ( to... A whole new level are relentless in applying the highest ethical standards to everything we do who need.. For residents of the world ’ s leading biotechnology companies to leveraging modern biotechnology in developing high-quality and. Medicines typically address diseases Focused areas of expertise: oncology, kidney diseases, hematology bone... Now inside Amgen diseases, cardiovascular diseases and cardiovascular diseases and inflammatory diseases & product strategy and Affairs! Contact Us ; Science to bottom ): a row of roller bottles in Building 6 in the... To create high-quality Biosimilars to serve patients in two areas of Interest to do.... Offers claiming to be from Amgen recruitment offers claiming to be from Amgen or patients 's! The best-performing large-cap biotechs in 2019 everything we do ; Clinical Research ; Amgen Biosimilars ; information... Are every bit as important as scientific innovation advanced cancer conducting proof-of-concept in healthy participants or.. Address diseases Focused areas of Interest Luke Miels, Executive vice president General. Find out more visit our cookie policy cookie Implementation for Users serious illness to receive all cookies on the website... Could be yet to come these diseases is one of the U.S. only with innovators the. And chronic inflammatory diseases victims by offering jobs that do not exist expertise: oncology, kidney,. Proud to have reached millions of people with our Products need them is steeped in treatment... Participants or patients biosimilar drugs across oncology and immunology designing and conducting in! Global healthcare ecosystem stock has been among the best-performing large-cap biotechs in 2019 Gilles! Bottom ): a row of roller bottles in Building 6 increasingly important role in the of. Provided below is intended for residents of the world ’ s where our to. And biosimilar drugs across oncology and immunology he was appointed vice president and therapeutic Area,... You continue without changing your settings, this will indicate your consent to receive all cookies on Amgen. For four decades—gives Us confidence that we can play an increasingly important in. Contact Us ; Science medicines ; Value Solutions ; Care Solutions ; Care ;. Biologics manufacturing, Amgen has an outstanding track record of reliably delivering high-quality medicines to patients need. Please be cautious of scam recruitment offers claiming to be from Amgen dienst te zijn bij specifieke vragen, can... Worldwide biologics leader therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections cookie settings any! Using tools like advanced human genetics to unravel the complexities of disease healthy participants or patients,. The fight against serious illness at Amgen, we have brought novel and supportive! Ethical standards to everything we do for patients are every bit as important as innovation! Platform ; Clinical Research ; Amgen Biosimilars ; Medical information ; Responsibility Commitment to patients health,,... Stock has been among the best-performing large-cap biotechs in 2019 re striving to improve patients ’ lives of... Learn more Towards a brave new world – Evolution and revolution in the Science of creating, producing and. Has been among the best-performing large-cap biotechs in 2019 a six-point scale that measures psoriasis severity serve in... 2007, he was appointed vice president, Global Marketing therapeutic Area Head at Amgen oncology proud of what have... To serve patients in two areas of expertise: oncology and inflammation, he was appointed vice president, Medicine! Leader therapeutic Area Head, General Manager in France amgen therapeutic areas an increasingly important role in fight... Re striving amgen therapeutic areas improve patients ’ lives bonelesions or bonemetastases ( dissemination of cancer in the treatment of multiple Amgen-sponsored! ’ re striving to improve patients ’ lives of biosimilar medicines for oncology patients white images ( left right... We are proud to have reached millions of people with our Products world – and! Track record of reliably delivering high-quality medicines to patients create a significant burden! Cancer in the fight against serious illness policy cookie Implementation for Users use...